Back to Search
Start Over
Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts.
- Source :
-
Critical care medicine [Crit Care Med] 2003 Mar; Vol. 31 (3), pp. 683-8. - Publication Year :
- 2003
-
Abstract
- Objective: hemolysin has been implicated as an important pathogenic factor in extraintestinal infections including sepsis. We investigated the effects of coronary administration of hemolysin on cardiac function in isolated rat hearts perfused at constant flow.<br />Design: Prospective, experimental study.<br />Setting: Research laboratory at a university hospital.<br />Subjects: Isolated hearts from male Wistar rats.<br />Interventions: Isolated hearts were perfused with purified hemolysin for 60 min.<br />Measurements and Main Results: Low concentrations of the toxin in the perfusate (0.1-0.2 hemolytic units/mL) caused a dose-dependent coronary vasoconstriction with a marked increase in coronary perfusion pressure, which was paralleled by a decrease in left ventricular developed pressure (and the maximum rate of left ventricular pressure increase). Moreover, 0.2 hemolytic units/mL hemolysin evoked ventricular fibrillation within 10 mins of toxin application. These events were accompanied by the liberation of leukotrienes (LTC4, LTD4, LTE4, and LTB4), thromboxane A2, prostaglandin I2, and the cell necrosis markers lactate dehydrogenase and creatine kinase into the recirculating perfusate. The lipoxygenase inhibitor MK-886 fully blocked the toxin-induced coronary vasoconstrictor response and the loss of myocardial contractility and reduced the release of lactate dehydrogenase and creatine kinase. In contrast to this, the cyclooxygenase inhibitor indomethacin was entirely ineffective. In addition, hemolysin elicited an increase in heart weight and left ventricular end-diastolic pressure, the latter again being suppressed by MK-886.<br />Conclusions: Low doses of hemolysin cause strong coronary vasoconstriction, linked with loss of myocardial performance, release of cell injury enzymes, and electrical instability, with all events being largely attributable to toxin-elicited leukotriene generation in the coronary vasculature. Bacterial exotoxins such as hemolysin thus may be implicated in the cardiac abnormalities encountered in septic shock.
- Subjects :
- Animals
Coronary Circulation
Dose-Response Relationship, Drug
Heart Failure immunology
Heart Failure physiopathology
In Vitro Techniques
Indoles pharmacology
Lipoxygenase Inhibitors pharmacology
Male
Prospective Studies
Rats
Shock, Septic immunology
Shock, Septic physiopathology
Ventricular Dysfunction, Left immunology
Ventricular Dysfunction, Left microbiology
Ventricular Dysfunction, Left physiopathology
Ventricular Fibrillation immunology
Ventricular Fibrillation physiopathology
Ventricular Pressure
Coronary Vessels physiopathology
Disease Models, Animal
Escherichia coli
Escherichia coli Infections complications
Exotoxins adverse effects
Heart Failure microbiology
Hemolysin Proteins adverse effects
Leukotrienes physiology
Myocardial Contraction
Shock, Septic microbiology
Vasoconstriction
Ventricular Fibrillation microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 0090-3493
- Volume :
- 31
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Critical care medicine
- Publication Type :
- Academic Journal
- Accession number :
- 12626969
- Full Text :
- https://doi.org/10.1097/01.CCM.0000050072.69509.06